THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- CRMTAmericas Carmart IncMaterial agreement.−36.3%8-K 1.01 ↗
- NPWRNet Power IncOfficer or director change.+7.8%8-K 5.02 ↗
- PEPGPepGen IncResults of operations and Regulation FD disclosure.+58.2%8-K 2.02 ↗
- AENTAlliance Entertainment Holding CorpShareholder vote.+3.8%8-K 5.07 ↗
- ASTSAST SpaceMobile, IncRegulation FD disclosure.
AST SpaceMobile to supply satellites to power Japan’s sovereign direct-to-device constellation
−36.9%8-K 7.01 ↗ - PMVPPMV Pharmaceuticals, IncResults of operations.−29.9%8-K 2.02 ↗
- ALHAlliance Laundry Holdings IncResults of operations.+1.0%8-K 2.02 ↗
- HIVEHIVE Digital Technologies LtdResults of operations.−36.2%8-K 2.02 ↗
- KLRSKalaris Therapeutics, IncResults of operations.−44.3%8-K 2.02 ↗
- MIRMMirum Pharmaceuticals, IncOther events.+3.2%8-K 8.01 ↗
- MCFTMasterCraft Boat Holdings, IncResults of operations.
MasterCraft Boat Holdings, Inc. Reports Results for the First Three Months of Its Transition Period
+4.0%8-K 2.02 ↗ - ECCEagle Point Credit CoOther events.+8.0%8-K 8.01 ↗
- XLOXilio Therapeutics, IncResults of operations.−16.0%8-K 2.02 ↗
- CDXSCodexis, IncMaterial agreement and unregistered sale of shares.−9.0%8-K 1.01 ↗
- XGNExagen IncResults of operations.−49.2%8-K 2.02 ↗
- LCIILci IndustriesOther events.−2.4%8-K 8.01 ↗
- AMBQAmbiq Micro, IncResults of operations.
Ambiq Reports Third Quarter 2026 Financial Results Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors Gross profit more than…
−13.3%8-K 2.02 ↗ - ENTGEntegris IncRegulation FD disclosure and other events.
Board authorizes $500 million share repurchase program
−11.1%8-K 7.01 ↗ - ABUSArbutus Biopharma CorpResults of operations.+8.1%8-K 2.02 ↗
- KUSTKustom Entertainment, IncResults of operations and Regulation FD disclosure.
KUSTOM ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER OPERATING RESULTS REVENUE UP 57%, NET INCOME REACHES $2.3 MILLION AND STOCKHOLDERS’ EQUITY MORE THAN TRIPLED SINCE YEAR END 2025 AS THE COMPANY…
−25.4%8-K 2.02 ↗ - EFOIEnergy Focus, IncResults of operations.
Energy Focus, Inc. Reports Third Quarter 2026 Financial Results
−32.4%8-K 2.02 ↗ - CLRBCellectar Biosciences, IncResults of operations.−37.7%8-K 2.02 ↗
- AUTLAutolus Therapeutics plcResults of operations and Regulation FD disclosure.−31.3%8-K 2.02 ↗
- CMCCOMMERCIAL METALS CoOfficer or director change and Regulation FD disclosure.
CMC Announces CFO Retirement and Succession Plan; Appoints Kenji Hashimoto as Deputy CFO
−15.4%8-K 5.02 ↗ - CALCCalciMedica, IncResults of operations.
CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates Auxora Phase 1b proof-of-concept data in pulmonary hypertension (PH) and CM5480 IND submission both…
−16.8%8-K 2.02 ↗ - SRRKScholar Rock Holding CorpMaterial agreement and results of operations.−6.6%8-K 1.01 ↗
- LNSRLENSAR, IncResults of operations.−18.3%8-K 2.02 ↗
- COAGHemab Therapeutics Holdings, IncResults of operations.
Expects to present data from the ongoing VELORA Pioneer Phase 1/2 trial of HMB-002 in Von Willebrand Disease at the 20th EAHAD (European Association for Haemophilia and Allied Disorders) Congress in…
−8.2%8-K 2.02 ↗ - CTYCity Therapeutics, IncRegulation FD disclosure.
City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease CITY-RBP4 is an RNAi therapeutic candidate designed to provide…
8-K 7.01 ↗ - PDYNPalladyne AI CorpResults of operations and Regulation FD disclosure.
Palladyne AI Reports Record Third Quarter 2026 Results Revenue increased 895% year-over-year and 48% sequentially to $8.6 million Raises bottom end of full-year 2026 revenue guidance to $25 million…
−33.1%8-K 2.02 ↗ - CGEMCullinan Therapeutics, IncResults of operations.−24.2%8-K 2.02 ↗
- SIONSionna Therapeutics, IncResults of operations.−20.9%8-K 2.02 ↗
- UPBUpstream Bio, IncResults of operations.
Upstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress - Company plans to initiate Phase 3 trials in both severe asthma and CRSwNP in the first quarter of 2027 -…
−55.6%8-K 2.02 ↗ - OLMAOlema Pharmaceuticals, IncResults of operations.−4.6%8-K 2.02 ↗
- MASS908 Devices IncResults of operations.
908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue Revenue increased 35% compared to prior year Raises low end of 2026 revenue outlook
−24.7%8-K 2.02 ↗ - HUMAHumacyte, IncResults of operations.−2.2%8-K 2.02 ↗
- OVIDOvid Therapeutics IncResults of operations.−22.8%8-K 2.02 ↗
- IRDOpus Genetics, IncResults of operations.−5.0%8-K 2.02 ↗
- QBTSD-Wave Quantum IncResults of operations.
D-Wave Reports Third Quarter 2026 Results Third Quarter Revenue Up 21% Year Over Year Remaining Performance Obligations of $38.3 Million Up 1,221% Year Over Year
−43.2%8-K 2.02 ↗ - SUNESUNation Energy, IncRegulation FD disclosure.−15.8%8-K 7.01 ↗
- ENVAEnova International, IncOther events.
ENOVA ANNOUNCES NEW $500 MILLION SHARE REPURCHASE PROGRAM
−2.7%8-K 8.01 ↗ - LQDALiquidia CorpResults of operations and other events.+13.7%8-K 2.02 ↗
- REFIChicago Atlantic Real Estate Finance, IncResults of operations and Regulation FD disclosure.−5.1%8-K 2.02 ↗
- HBIOHarvard Bioscience IncRegulation FD disclosure.−4.7%8-K 7.01 ↗
- HBIOHarvard Bioscience IncResults of operations.
Reaffirms Full Year 2026 Revenue Guidance of 3%-5% Year Over Year Growth
−4.7%8-K 2.02 ↗ - JBIJanus International Group, IncResults of operations and Regulation FD disclosure.
JANUS INTERNATIONAL GROUP REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
−31.3%8-K 2.02 ↗ - PLXProtalix BioTherapeutics, IncResults of operations.
Cash, cash equivalents, and short-term bank deposits were $48.5 million as of September 30, 2026
+12.8%8-K 2.02 ↗ - SBHSally Beauty Holdings, IncResults of operations and Regulation FD disclosure.−9.1%8-K 2.02 ↗
- NVANova Minerals CorpRegulation FD disclosure.
Nova Minerals Confirms 216,000 tpa Processing Capacity, Advancing Alaska’s Critical Minerals Hub
−54.8%8-K 7.01 ↗ - WYFIWhiteFiber, IncMaterial agreement and new debt or obligation.−33.6%8-K 1.01 ↗